Cherryrock Capital

Cherryrock Capital is a San Francisco-based venture capital firm, founded in 2023, that provides Series A and B financing to transformative software companies led by underinvested founders. Its $172 million debut fund closed in January 2025, with LPs including JPMorgan, Goldman Sachs, and MassMutual. Its operator team brings 60+ years of combined operating experience, helping companies scale to $100 million in revenue through operational excellence, CEO coaching, and talent support. Investments include Flourish Health, Vori, Certiverse, Vitable Health, and Coactive AI, and it takes board seats in rounds it leads. It focuses on fintech, digital health, enterprise SaaS and AI, future of work and education, and consumer enablement, with checks of $2 million to $15 million. Cherryrock holds that startups with underinvested founders become unicorns at 11 times the average rate when properly resourced.